Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Armando Sardi

Dr. Armando Sardi

Medical Director, Surgical Oncologist

Renowned surgical oncologist Dr. Armando Sardi is the medical director of the Institute for Cancer Care at Mercy Medical Center in Baltimore and a specialist in the treatment of peritoneal mesothelioma.

Get in touch
Jump to a Topic:

About Armando Sardi

Accolades
  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

  • Mesothelioma Pioneer icon

    Mesothelioma Pioneer

  • Team Leader icon

    Team Leader

  • Research Excellence icon

    Excellence in Research

Get to Know Dr. Armando Sardi

Surgical oncologist Dr. Armando Sardi has been a pioneer in advancing the treatment of peritoneal malignancies, earning his reputation with an ability to successfully treat late-stage, complex cancers.

He was one of the first to use the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), which has extended survival time dramatically for patients diagnosed with peritoneal mesothelioma.

Sardi continues refining and improving the procedure, performing an estimated eight to 10 each month for various abdominal cancers. He has successfully treated patients that others have turned away.

His reputation has attracted mesothelioma patients from across the country, many of whom have lived far beyond initial expectations.

Sardi also treats patients with a wide variety of abdominal disorders, including tumors of the digestive system and gastrointestinal tract, thyroid, pancreas and liver. He treats colorectal and appendiceal cancers.

As co-chair of the cancer committee at Mercy, he is active on the tumor board, which includes surgeons, oncologists, radiologists and nurses who meet regularly to collaborate and discuss each case.

Sardi was named to the “100 Most Influential Expatriates” list in Colombia, where his nonprofit, Partners for Cancer Care and Prevention, has helped thousands.

Specialties of Dr. Armando Sardi

  • Hyperthermic intraperitoneal chemotherapy (HIPEC)

  • Cytoreductive surgery

  • Peritoneal mesothelioma

  • Research

  • Laparoscopy

  • Hepatic artery embolization

  • Liver cancer

  • Pancreatic cancer

  • Colorectal cancer

Dr. Armando Sardi’s Experience and Medical Education

  • Institute for Cancer Care, Mercy Medical Center

  • Ohio State University Wexner Medical Center (Fellowship)

  • Saint Agnes Hospital (Residency)

  • Universidad del Valle, Cali, Colombia (MD)

Awards and Other Recognitions

  • 100 Most Influential Expatriates (Colombia)

  • Medical Geniuses that Make Colombia Proud

  • Hispanic Hero Award for Excellence, Medical/Social Entrepreneur

  • America’s Top Doctors

  • America’s Top Doctors for Cancer

Mesothelioma Clinical Trials Under Dr. Armando Sardi

  • Clinical trial studying the gastrointestinal microbiome of appendiceal cancer for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  • A phase II clinical trial studying the toxicity of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced stage ovarian and primary peritoneal cancer.

Sardi is a Pioneer of Peritoneal Malignancies Treatment

Sardi has spent considerable time training others on the cytoreduction and HIPEC combination, traveling the world talking about how to treat abdominal cancers most effectively.

“Cytoreduction is not going in and removing a few tumors. Cytoreduction is going in and doing an extensive surgery,” he said. “Unfortunately, it still is being done the wrong way in a lot of places. Too many patients are still being told there is nothing they can do, when there actually is something they can do.”

Sardi has authored more than 120 medical papers, many of which describe his pioneering work with peritoneal malignancies.

“Mesothelioma is a rare disease, which is why it is so frequently mismanaged,” he said. “People don’t know how to deal with it, don’t know how to treat it. That’s the real problem still today, and people are being hurt by that.”

See More Top Mesothelioma Doctors

Publications of Dr. Armando Sardi

  • Sardi, A. et al. (2019, July 5). Overcoming Barriers in the Implementation of Programs for Breast and Cervical Cancers in Cali, Colombia: A Pilot Model. Journal of Global Oncology.

  • Sardi, A. et al. (2018, May 2). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma. Clinical Case Reports.

  • Sardi, A. et al. (2017, November). Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology.

Disclaimer: Dr. Armando Sardi has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at Asbestos.com
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 31, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now